The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetesGASTALDELLI, Amalia; BRODOWS, Robert G; D'ALESSIO, David et al.Clinical endocrinology (Oxford. Print). 2014, Vol 80, Num 4, pp 545-553, issn 0300-0664, 9 p.Article

The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes : A randomized trial. CommenatryZINMAN, Bernard; HOOGWERF, Byron J; DURAN GARCIA, Santiago et al.Annals of internal medicine. 2007, Vol 146, Num 7, issn 0003-4819, 477-485, 527-528 [11 p.]Article

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes : A randomized trialHEINE, Robert J; VAN GAAL, Luc F; JOHNS, Don et al.Annals of internal medicine. 2005, Vol 143, Num 8, pp 559-569, issn 0003-4819, 11 p.Article

Efficacy and Tolerability of Exenatide Monotherapy Over 24 Weeks in Antidiabetic Drug-Naive Patients with Type 2 Diabetes : A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyMORETTO, Thomas J; MILTON, Denai R; RIDGE, Terry D et al.Clinical therapeutics. 2008, Vol 30, Num 8, pp 1448-1460, issn 0149-2918, 13 p.Article

Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agentsDAVIS, Stephen N; JOHNS, Don; MAGGS, David et al.Diabetes care. 2007, Vol 30, Num 11, pp 2767-2772, issn 0149-5992, 6 p.Article